Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022

Author's Avatar
Jul 01, 2022

Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Revenues for the Quarter Ended March 31, 2022